This event has ended. Visit the official site or create your own event on Sched.
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
Back To Schedule
Friday, April 29 • 12:15pm - 1:45pm
Transforming Blood Cancer Care, the Role of Clinical Trials and CAR T-Cell Therapy

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

There has been great progress in treatment, but for most blood cancers, there is no cure and better therapies are needed. In this symposium, new and evolving treatment strategies will be discussed, including how the heterogeneous nature of blood cancers dictates treatment and prognosis, the role of clinical trials, and the evolving role of CAR T-cell therapy.  Cases will focus on acute myeloid leukemia (AML) and on diffuse large B-cell lymphoma (DLBCL). 

Sponsored by The Leukemia & Lymphoma Society and supported by educational grants from Kite Pharma, Inc. and Stemline Therapeutics, Inc.

Please click here to register for this event. 

Friday April 29, 2016 12:15pm - 1:45pm CDT
Hemisfair Ballroom